Effects of PTH(1-34) on blood pressure, renal function, and hormones in essential hypertension: The altered pattern of reactivity may counteract raised blood pressure

American Journal of Hypertension

Volumn 10, Issue 12 I, 1997, Pages 1356-1367

  Jespersen, Bente ^a   Randløv, Annette ^a   Abrahamsen, Jan ^a   Fogh Andersen, Niels ^a   Kanstrup, Inge Lis ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Essential hypertension; Glomerular filtration rate; Hormones; Renal plasma flow; Sodium excretion

Indexed keywords

ALBUMIN; ALDOSTERONE; BETA 2 MICROGLOBULIN; ENDOTHELIN; IODINE 131; LITHIUM CARBONATE; NORADRENALIN; PARATHYROID HORMONE[1-34]; PENTETATE TECHNETIUM TC 99M; RENIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GLOMERULUS FILTRATION RATE; HEMODYNAMIC PARAMETERS; HORMONAL REGULATION; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; MALE; PRIORITY JOURNAL; SODIUM EXCRETION;

ADULT; BETA 2-MICROGLOBULIN; BLOOD PRESSURE; BODY WATER; CALCIUM; CARDIAC OUTPUT; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; PULSE; SODIUM; TERIPARATIDE;

EID: 0031426287     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00275-6     Document Type: Article

References (58)

1. Nakamura T, Ichikawa S, Sakamaki T, et al. Effect of saline infusion on urinary calcium excretion in essential hypertension. Am J Hypertens. 4:1991;113-118.
2. Young EW, McCarron DA, Morris CD. Calcium regulating hormones in essential hypertension Importance of gender . Am J Hypertens. 3:1990;161S-166S.
3. Papagalanis ND, Skopelitis P, Kourti A, et al. Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension. Nephron. 59:1991;226-231.
4. Sancho JJ, Rouco J, Riera-Vidal R, Sitges-Serra A. Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension. World J Surg. 16:1992;732-736.
5. Duprez D, Bauwens F, De Buyzere M, et al. Relationship between parathyroid hormone and left ventricular mass in moderate essential hypertension. J Hypertens. 9:(suppl 6):1991;S116-S117.
6. Jespersen B, Brock A, Pedersen EB. Lack of effect of calcium carbonate supplementation on 24h blood pressure, angiotensin II reactivity and PTH(1-84) in essential hypertension. J Hum Hypertens. 7:1993;103-104.
7. Brickman A, Nyby M, von Hungen K, et al. Parathyroid hormone, platelet calcium, and blood pressure in normotensive subjects. Hypertension. 18:1991;176-182.
8. Campese VM. Calcium, parathyroid hormone, and blood pressure. Am J Hypertens. 2:1989;34S-44S.
9. Wang H-H, Drugge ED, Yen Y-C, et al. Effects of synthetic parathyroid hormone on hemodynamics and regional blood flows. Eur J Pharmacol. 97:1984;209-215.
10. Agus ZS, Puschett JB, Senesky D, Goldberg M. Mode of action of parathyroid hormone and cyclic adenosine 3′,5′-monophosphate on renal tubular phosphate reabsorption in the dog. J Clin Invest. 50:1971;617-626.
11. Czekalski S, Loreau N, Paillard F, et al. Effect of bovine parathyroid hormone 1-34 fragment on renal production and excretion of adenosine 3′,5′ monophosphate in man. Eur J Clin Invest. 4:1974;85-92.
12. Helwig J-J, Musso M-J, Clement J, Nickols GA. Parathyroid hormone and calcium interactions in the control of renin secretion in the isolated, nonfiltering kidney . Endocrinology. 129:1991;1233-1242.
13. Enhancement of the stimulatory effect of calcium on aldosterone secretion by parathyroid hormone. Miner Electrolyte Metab. 20:1994;309-314.
14. Neuser D, Schulte-Brinkmann R, Kazda S. Influence of transplantation of parathyroid glands on blood pressure development in stroke prone spontaneously hypertensive rats and in normotensive Wistar Kyoto rats. Clin Exp Hypertens [A]. A13:1991;325-338.
15. + exchanger in spontaneously hypertensive rats. Am J Physiol. 261:1991;F526-F536.
16. Dipette DJ, Christenson W, Nickols MA, Nickols GA. Cardiovascular responsiveness to parathyroid hormone (PTH) and PTH-related protein in genetic hypertension. Endocrinology. 130:1992;2045-2051.
17. Cappuccio FP, Markandu ND, Beynon GW, et al. Effect of increasing calcium intake on urinary sodium excretion in normotensive subjects. Clin Sci. 71:1986;453-456.
18. Shingu T, Matsuura H, Kusaka M, et al. Significance of intracellular free calcium and magnesium and calcium-regulating hormones with sodium chloride loading in patients with essential hypertension. J Hypertens. 9:1991;1021-1028.
19. McCarron DA, Pingree PA, Rubin RJ, et al. Enhanced parathyroid function in essential hypertension a homeostatic response to a urinary calcium leak . Hypertension. 2:1980;162-168.
20. Young EW, Morris CD, McCarron DA. Urinary calcium excretion in essential hypertension. J Lab Clin Med. 120:1992;624-632.
21. Strazzullo P, Nunziata V, Cirillo M, et al. Abnormalities of calcium metabolism in essential hypertension. Clin Sci. 65:1983;137-141.
22. Galletti F, Ferrara I, Stinga F, et al. Effect of intravenous sodium chloride on renal sodium and calcium handling in hypertensive patients with different sensitivities to sodium chloride. J Hypertens. 11:(suppl 5):1993;S194-S195.
23. Bucher HC, Cook RJ, Guyatt GH, et al. Effects of dietary calcium supplementation on blood pressure A meta-analysis of randomized controlled trials . JAMA. 275:1996;1016-1022.
24. Hamet P, Daignault-Gélinas M, Lambert J, et al. Epidemiological evidence of an interaction between calcium and sodium intake impacting on blood pressure A Montréal study . Am J Hypertens. 5:1992;378-385.
25. Hulter HN, Melby JC, Peterson JC, Cooke CR. Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens. 4:1986;360-370.
26. Ruilope LM, Oliet A, Alcázar JM, et al. Characterization of the renal effects of an intravenous calcium gluconate infusion in normotensive volunteers. J Hypertens. 7:(suppl 6):1989;S170-S171.
27. Schwarz P, Sørensen HA, Transbøl I, McNair P. Induced hypocalcaemia controlled by a citrate clamp technique, and the intact parathyroid hormone response obtained. Scand J Clin Lab Invest. 50:1990;891-897.
28. Roelen DL, Frölich M, Papapoulos SE. Renal responsiveness to synthetic human parathyroid hormone 1-38 in healthy subjects. Eur J Clin Invest. 19:1989;311-315.
29. Thomsen K: Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 1984;37:217-123.
30. Halbrügge T, Gerhardt T, Ludwig J, et al. Assay of catecholamines and dihydroxyphenylethleneglucol in human plasma and its application in orthostasis and mental stress. Life Sci. 43:1988;19-26.
31. Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay an improved determination of urinary albumin in diabetics with incipient nephropathy . Scand J Clin Lab Invest. 45:1985;539-544.
32. Feldt-Rasmussen B, Deckert M, Dinesen B. Beta-2-microglobulin in urine and serum determined by a micro-ELISA technique. Scand J Clin Lab Invest. 46:1986;791-793.
33. 2-rebreathing and the direct Fick method . Acta Anaesthesiol Scand. 39:1995;245-251.
34. Tomlinson S, Hendy GN, Pemberton DM, O'Riordan JLH. Reversible resistance to the renal action of parathyroid hormone in man. Clin Sci Mol Med. 51:1976;59-69.
35. Seshadri MS, Chan YL, Wilkinson MR, et al. Some problems associated with adenylate cyclase bioassays for parathyroid hormone. Clin Sci. 68:1985;311-319.
36. McCarron DA, Ellison DH, Anderson S. Vasodilation mediated by human PTH 1-34 in the spontaneously hypertensive rat. Am J Physiol. 246:1984;F96-F100.
37. Bogin E, Massry S, Harary I. Effect of parathyroid hormone on rat heart cells. J Clin Invest. 67:1981;1215-1227.
38. Wang R, Karpinski E, Pang PKT. Parathyroid hormone selectively inhibits L-type voltage-dependent calcium channels in single vascular smooth muscle cells. J Physiol. 441:1991;325-346.
39. Jordan LR, Dallemagne CR, Cross RB. Cardiovascular effects of parathyroid hormone in conscious sheep. Exp Physiol. 76:1991;251-257.
40. Ferguson CJ, Williams JD, Silver A, et al. Effects of parathyroid hormone on delayed renal allograft function. Br Med J. 303:1991;287-288.
41. Trizna W, Edwards RM. Relaxation of renal arterioles by parathyroid hormone and parathyroid hormone-related protein. Pharmacology. 42:1991;91-96.
42. Marchand GR. Effect of parathyroid hormone on the determinants of glomerular filtration in dogs. Am J Physiol. 248:1985;F482-F486.
43. Humes HD, Ichikawa I, Troy JL, Brenner BM. Evidence for a parathyroid hormone-dependent influence of calcium on the glomerular ultrafiltration coefficient. J Clin Invest. 61:1978;32-40.
44. Zoccali C, Mallamaci F, Postorino M, et al. Hyperfiltration and calcium metabolism in essential hypertension. Am J Hypertens. 4:1991;944-950.
45. 2-microglobulin, lysozyme and albumin (thesis). Scand J Urol Nephrol 1973;(suppl 20).
46. 2+ fluxes . J Clin Invest. 76:1985;1147-1154.
47. Boer WH, Fransen R, Shirley DG, et al. Evaluation of the lithium clearance method direct analysis of tubular lithium handling by micropuncture . Kidney Int. 47:1995;1023-1030.
48. Steele TH, Manuel MA, Newton M, Boner G. Renal lithium reabsorption in man physiologic and pharmacologic determinants . Am J Med Sci. 269:1975;349-363.
49. Costanzo LS, Windhager EE. Effects of PTH, ADH, and cyclic AMP on distal tubular Ca and Na reabsorption. Am J Physiol. 239:1980;F478-F485.
50. 2-adrenoceptor regulation of parathyroid hormone function in the isolated perfused kidney. Clin Exp Hypertens [A] 1989; All(suppl 1):133-148.
51. Resnick LM. Calcium metabolism in hypertension and allied metabolic disorders. Diabetes Care. 14:1991;505-520.
52. Jespersen B, Fogh-Andersen N, Brock A. Parathyroid hormone in blood pressure and volume homeostasis in healthy subjects, hyperparathyroidism, liver cirrhosis and glomerulonephritis A possible interaction with angiotensin II and atrial natriuretic peptide . Scand J Clin Lab Invest. 54:1994;531-541.
53. Grant FD, Mandel SJ, Brown EM, et al. Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab. 75:1992;988-992.
54. Isales CM, Barrett PQ, Brines M, et al. Parathyroid hormone modulates angiotensin II-induced aldosterone secretion from the adrenal glomerulosa cell. Endocrinology. 129:1991;489-495.
55. Jespersen B, Pedersen EB, Charles P, et al. Elevated angiotensin II and vasopressin in primary hyperparathyroidism Angiotensin II infusion studies before and after removal of the parathyroid adenoma . Acta Endocrinol. 120:1989;362-368.
56. Jespersen B, Brock A, Charles P, et al. Unchanged noradrenaline reactivity and blood pressure after corrective surgery in primary hyperparathyroidism. Scand J Clin Lab Invest. 53:1993;479-486.
57. Lewanczuk RZ, Pang PKT. Expression of parathyroid hypertensive factor in hypertensive primary hyperparathyroid patients. Blood pressure. 2:1993;22-27.
58. Young EW, Morris CD, Holcomb S, et al. Regulation of parathyroid hormone and vitamin D in essential hypertension. Am J Hypertens. 8:1995;957-964.